drugset / Trial / NCT01701778

Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children

NCT01701778 ↗

Phase 2 Completed 90 enrolled Yao Yusheng West China Hospital · collab
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to compare the effects of caudal dexmedetomidine with intravenous dexmedetomidine on caudal levobupivacaine analgesia in children undergoing lower abdominal surgeries.

Timeline

Start
2012-10
Primary completion
2014-01
Completion
2014-01

Outcome

Met primary endpoint

paper median duration of analgesia in the L-Dcau group was 14.2 hour compared to 6 hour in the L group with a median difference of 8.5 hour PMID 30302881 ↗

paper with a median difference of 8.5 hour [95% CI (6.5, 10.5), P <0.001]. PMID 30302881 ↗

paper The median duration of analgesia in the L-Div group was 12.4 hour compared to 6 hour in the L group with a median difference of 6.4 hour [95% CI (4, 8.5), P <0.001]. PMID 30302881 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1 ug/kg Other
Background Levobupivacaine Other / unclassified 0.25 % Other
Background Sevoflurane Other / unclassified — —

Indications